04:08 PM EDT, 03/24/2026 (MT Newswires) -- Theresa Heggie, Director, on March 20, 2026, sold 49,933 shares in Biocryst Pharmaceuticals ( BCRX ) for $504,823. Following the Form 4 filing with the SEC, Heggie has control over a total of 65,352 common shares of the company, with 65,352 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/882796/000088279626000017/xslF345X05/form4.xml